最後更新：2026年10月1日
腫瘤性疾病,需完整診斷分期並制定多模式治療計劃。預後取決於腫瘤類型、分期與治療反應。
Lymphoma is the most common feline malignancy. Alimentary (GI) lymphoma predominates, with small cell (low-grade) vs large cell (high-grade) distinction guiding prognosis and treatment. FeLV-associated mediastinal lymphoma has decreased with vaccination. Injection-site sarcoma (feline injection-site sarcoma, FISS) requires wide surgical margins (3-5 cm).
Lymphoma is one of the most common canine cancers, with multicentric form predominating. CHOP-based protocols are standard of care. Hemangiosarcoma (spleen, right atrium, liver) is overrepresented in German Shepherds and Golden Retrievers. Mast cell tumors are the most common cutaneous neoplasm in dogs.
這頁有幾個欄位是同系統共用的模板，還沒針對本疾病單獨改寫過。請以臨床判斷為準，記得對照下方文獻。
多黏菌素B。NSAID
加巴噴丁。Gabapentinoid (Anticonvulsant / Analgesic)
建議：化療前後積極利尿（cisplatin）或維持量
| 藥物 | 劑量 | 頻率 | 路徑 | 優先級 |
|---|---|---|---|---|
| Doxorubicin Hydrochloride 多柔比星。Anticancer agent | 犬 30 mg/m2 q21 days IV；貓 20-25 mg/m2 q21 days IV | 依醫囑 | IV | 首選 |
| Butorphanol Tartrate 布托啡諾。Analgesic | 犬 0.1-0.5 mg/kg q4-6h IV/IM/SC；貓 0.05-0.2 mg/kg q4-6h IV/IM/SC | Q4-6H | IV | 首選 |
| 藥物 | 劑量 | 頻率 | 優先級 |
|---|---|---|---|
| Polymyxin B 多黏菌素B。NSAID | 犬 Refer to current formulary for species-specific dosing；貓 Refer to current formulary for species-specific dosing | 依醫囑 | 首選 |
| Gabapentin 加巴噴丁。Gabapentinoid (Anticonvulsant / Analgesic) | 犬 5-10 mg/kg q8-12h PO；貓 5-10 mg/kg q8-12h PO | Q8-12H | 首選 |
監測頻率：化療後 7-10d (nadir)
[1]Surgical approaches to canine appendicular osteosarcoma part 2 - limb-sparing techniques.
[2]Osteosarcoma of the appendicular skeleton in dogs: consensus and guidelines.
[3]Survival and functional outcomes following surgical repair of pathological fractures in dogs: A meta-analysis.
穩定但需注意惡化徵兆，建議安排近期門診 (stable but monitor for deterioration, schedule near-term visit)
預後高度變異,取決於腫瘤類型、分級、分期與治療方式。早期診斷與積極治療可延長存活期。
Osteosarcoma Limb Sparing 診斷流程
詳細問診包括發病經過、用藥史、飲食與環境
CBC、生化全套、尿液分析
來源：自動產生